0001104659-24-008883.txt : 20240131 0001104659-24-008883.hdr.sgml : 20240131 20240131171635 ACCESSION NUMBER: 0001104659-24-008883 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240129 FILED AS OF DATE: 20240131 DATE AS OF CHANGE: 20240131 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weisman Howard J. CENTRAL INDEX KEY: 0001811802 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41475 FILM NUMBER: 24583947 MAIL ADDRESS: STREET 1: C/O PAXMEDICA, INC. STREET 2: 900 E. HAMILTON AVENUE, SUITE 100 CITY: CAMPBELL STATE: CA ZIP: 95008 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PaxMedica, Inc. CENTRAL INDEX KEY: 0001811623 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 303 SOUTH BROADWAY, SUITE 125 CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 914-987-2876 MAIL ADDRESS: STREET 1: 303 SOUTH BROADWAY, SUITE 125 CITY: TARRYTOWN STATE: NY ZIP: 10591 4 1 tm244774-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-01-29 0 0001811623 PaxMedica, Inc. PXMD 0001811802 Weisman Howard J. C/O PAXMEDICA, INC. 303 SOUTH BROADWAY, SUITE 125 TARRYTOWN NY 10591 1 1 0 0 Chief Executive Officer 0 Common Stock 2024-01-29 4 S 0 372 0.47 D 37675 D The sales reported in this Form 4 were effected pursuant to the Reporting Person's pre-existing Rule 10b5-1 trading plan to, inter alia, pay tax withholding on vested RSUs. The sale price represents the weighted average sale price of the shares sold ranging from $0.47 to $0.48 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. /s/ Stephen D. Sheldon, Jr. Attorney-in-Fact 2024-01-31